Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples
Open Access
- 31 March 1998
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (7) , 3873-3878
- https://doi.org/10.1073/pnas.95.7.3873
Abstract
Chromosome region 11p15.5 harbors unidentified genes involved in neoplasms and in the genetic disease Beckwith–Wiedemann syndrome. The genetic analysis of a 170-kb region at 11p15.5 between loci D11S601 and D11S679 resulted in the identification of six transcriptional units. Three genes, hNAP2, CDKN1C, and KVLQT1, are well characterized, whereas three genes are novel. The three additional genes were designated BWR1A, BWR1B, and BWR1C. Full-length cDNAs for these three genes were cloned and nucleotide sequences were determined. While our work was in progress, BWR1C cDNA was described as IPL [Qian, N., Franck, D., O’Keefe, D., Dao, D., Zhao, L., Yuan, L., Wang, Q., Keating, M., Walsh, C. & Tycko, B. (1997) Hum. Mol. Genet. 6, 2021–2029]. The cloning and mapping of these genes together with the fine mapping of the three known genes indicates that the transcriptional map of this region is likely to be complete. Because this region frequently is altered in neoplasms and in the genetic disease Beckwith–Wiedemann syndrome, we carried out a mutational analysis in tumor cell lines and Beckwith–Wiedemann syndrome samples that resulted in the identification of genetic alterations in the BWR1A gene: an insertion that introduced a stop codon in the breast cancer cell line BT549 and a point mutation in the rhabdomyosarcoma cell line TE125-T. These results indicate that BWR1A may play a role in tumorigenesis.Keywords
This publication has 40 references indexed in Scilit:
- A Novel Gene Product that Couples TCR Signaling to Fas(CD95) Expression in Activation-Induced Cell DeathImmunity, 1996
- Localization of a Tumor Suppressor Gene in 11p15.5 Using the G401 Wilms' Tumor AssayHuman Molecular Genetics, 1996
- Epigenetic lesions at the H19 locus in Wilms' tumour patientsNature Genetics, 1994
- Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumourNature Genetics, 1994
- Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11 p and 17p in medulloblastomasNeuropathology and Applied Neurobiology, 1994
- Tumour-suppressor activity of H19 RNANature, 1993
- Frequent loss of 11p13 and 11p15 loci in male germ cell tumoursGenes, Chromosomes and Cancer, 1993
- Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumorsGenomics, 1992
- Suppression of Tumorigenicity in Wilms Tumor by the p15.5-p14 Region of Chromosome 11Science, 1991
- Loss of heterozygosity in human germinal tumorsCytogenetic and Genome Research, 1989